J. Arnold Wealth Management’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

J. Arnold Wealth Management’s Portfolio FTXH Stock Details FTXH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-595	Closed	-$16K	–	49
2021 Q4	$16K	Sell	595 -19,451	-97%	-$511K	0.01%	46
2021 Q3	$517K	Sell	20,046 -7,881	-28%	-$207K	0.25%	27
2021 Q2	$723K	Buy	27,927 +1,497	+6%	+$38.7K	0.35%	26
2021 Q1	$676K	Sell	26,430 -346,122	-93%	-$9.07M	0.37%	27
2020 Q4	$9.6M	Buy	372,552 +91,199	+32%	+$2.27M	5.67%	6
2020 Q3	$6.78M	Buy	281,353 +107,677	+62%	+$2.58M	5.03%	6
2020 Q2	$3.95M	Buy	173,676 +98,351	+131%	+$2.18M	3.31%	6
2020 Q1	$1.46M	Sell	75,325 -75,358	-50%	-$1.64M	4.27%	7
2019 Q4	$3.51M	Buy	+150,683	New	+$3.28M	4.5%	7

Other funds holding FTXH

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

IAN

Integrated Advisors Network Dallas, Texas $1.91B AUM 24.91% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

LJAC

L.J. Altfest & Co New York $935M AUM 27.19% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

J. Arnold Wealth Management's FTXH Position: Q1 2022 in Review

J. Arnold Wealth Management sold out of First Trust Nasdaq Pharmaceuticals ETF (FTXH) in Q1 2022, closing a stake of 595 shares — an estimated $16K sold.

J. Arnold Wealth Management first reported a position in FTXH in Q4 2019 and held it in 9 quarters. The position peaked at $9.6M in Q4 2020. 17 funds tracked by Wall St. Rank hold FTXH as of Q1 2022.

J. Arnold Wealth Management reported no remaining First Trust Nasdaq Pharmaceuticals ETF position as of Q1 2022 after selling out during the quarter.
J. Arnold Wealth Management sold 595 First Trust Nasdaq Pharmaceuticals ETF shares in Q1 2022, an estimated $16K.
J. Arnold Wealth Management first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q4 2019 and held it in 9 quarters.
J. Arnold Wealth Management's First Trust Nasdaq Pharmaceuticals ETF position peaked at $9.6M in Q4 2020.
17 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q1 2022.

Based on J. Arnold Wealth Management's 13F filing for Q1 2022, filed 16 May 2022.